BIM:PA Biomerieux SA

EUR 104.60 0.00 0
Icon

Biomerieux SA (BIM:PA) Stock Analysis and Price Targets

COMMON STOCK | Diagnostics & Research | PA
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

EUR 104.60

0.00 (0.00)%

EUR 12.36B

0.15M

N/A

N/A

Icon

BIM:PA

Biomerieux SA (EUR)
COMMON STOCK | PA
EUR 104.60
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

EUR 12.36B

N/A

EUR 104.60

Biomerieux SA (BIM:PA) Stock Forecast

N/A

Based on the Biomerieux SA stock forecast from 0 analysts, the average analyst target price for Biomerieux SA is not available over the next 12 months. Biomerieux SA’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Biomerieux SA is Bullish , which is based on 11 positive signals and 4 negative signals. At the last closing, Biomerieux SA’s stock price was EUR 104.60. Biomerieux SA’s stock price has changed by +9.99% over the past week, +4.13% over the past month and +6.13% over the last year.

No recent analyst target price found for Biomerieux SA
No recent average analyst rating found for Biomerieux SA

Company Overview Biomerieux SA

bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the...Read More

https://www.biomerieux.com

376 Chemin De l?Orme, Marcy l'Étoile, France, 69280

13,409

December

EUR

France

Adjusted Closing Price for Biomerieux SA (BIM:PA)

Loading...

Unadjusted Closing Price for Biomerieux SA (BIM:PA)

Loading...

Share Trading Volume for Biomerieux SA Shares

Loading...

Compare Performance of Biomerieux SA Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for BIM:PA

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Biomerieux SA (Sector: Diagnostics & Research )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ERF:PA
Eurofins Scientific SE 0.00 (0.00%) EUR11.54B 38.09 11.78

ETFs Containing BIM

Symbol Name BIM's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Biomerieux SA (BIM:PA) Stock

Stock Target Advisor's fundamental analysis for Biomerieux SA's stock is Bullish .

BIM:PA stock's dividend yield is 0.81%. Our analysis grades BIM:PA stock's dividend yield at F. This means that BIM:PA stock's dividend yield is above 50% of the stocks in the Diagnostics & Research sector in the PA exchange. Based on this BIM:PA may be a average dividend stock for its sector.

Unfortunately we do not have enough data on BIM:PA's stock to indicate what its average analyst target is.

BIM:PA stock's Price/Earning ratio is 34.75. Our analysis grades BIM:PA stock's Price / Earning ratio at A+. This means that BIM:PA stock's Price/Earning ratio is above 0% of the stocks in the Diagnostics & Research sector in the PA exchange. Based on this BIM:PA may be undervalued for its sector.

The last closing price of BIM:PA's stock was EUR 104.60.

The most recent market capitalization for BIM:PA is EUR 12.36B.

Unfortunately we do not have enough analyst data on BIM:PA's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Biomerieux SA's stock.

As per our most recent records Biomerieux SA has 13,409 Employees.

Biomerieux SA's registered address is 376 Chemin De l?Orme, Marcy l'Étoile, France, 69280. You can get more information about it from Biomerieux SA's website at https://www.biomerieux.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...